Advances in Surgery 47 (2013) 329–333

ADVANCES IN SURGERY

INDEX

A

Abdominal aortic aneurysm, medical therapyof, 276–278

Not

0065http:/

repair of, early readmission after,frequency of, 142–143

e: Pa

-341/dx.

nonruptured, factors related to,145–146

readmission after, 141–152

ge nu

1/13doi.o

conceptual models of, andprevention ofreadmission, 148–151

consequences of, 147–148

endovascular andnonruptured,readmission after, 144

predictors of, 143–147

reasons for, 143

rupture of, biomechanical wallproperties influencing, 274–275

determinants of, 273–276

rapid expansion influencing,273–274

rate of, 271–286

smoking cessation influencing,275–276, 281

screening of, 278–279

surgical interventions in, role of, 279–281

treatment of, 272

Abdominal vascular surgery, changes in, 253

Abdominal wall musculature, 3–5

Abscess, postoperative, outcomes in patientsdeveloping, 116

Adults, severely burned, beta blockade in,180

Ambulatory surgery, laboratory testsrequired for, 81–98

American Board of Surgery examinationperformance, surgical residents and,260–261

mbers of article titles are in bold

/$ – see front matterrg/10.1016/S0065-3411(13)00

American Joint Committee on Cancer, 200,201, 202

Aneurysm, abdominal aortic. See Abdominalaortic aneurysm.

Angiotensin inhibitors, in abdominal aorticaneurysm, 278

Antibiotic therapy, in abdominal aorticaneurysm, 278

Appendectomy, incidental, 133

face

ª028-6

interval, 133–134

laparoscopic, for perforatedappendicitis, peritoneal lavage withsuction during, 111–118

negative, 300–308

Appendiceal mass, management advancesand controversies in, 126–130

nonoperative management of, 126

open versus laparoscopic managementof, 126–128

Appendicitis, acute, timing of operation for,130–133

appendectomy for, incidentalmalignancies after, 121

changing perspectives on, 119–139

CT scan in, 122–126

diagnosis of, clinical evaluation for,309–322

type

201

computed tomography for,312–314, 318–319, 321, 322

diagnostic laparoscopy for, 320

improvement in, 299–328

.

3 Else

evidence for, 299–308

strategies for, 309–322

in pediatric patients, 322

in pregnant patients, 320–322

magnetic resonance imaging in,315, 319–320, 321

practical score for (Alvaradoscore), 316

vier Inc. All rights reserved.

330 INDEX

Appendicitis (continued)

ultrasound for, 310–311, 317–318,321, 322

diagnostic advances and controversiesin, 121–126

during pregnancy, 128–130

epidemiology of, 120–121

perforated, laparoscopic appendectomyfor, peritoneal lavage with suctionduring, 111–118

ultrasound in, 122, 123, 124

Appendicitis inflammatory response score(Andersson score), 317

Appendix, with hole, 115

B

Beta blockade, in severely burned adults, 180

Beta-blocker therapy, in abdominal aorticaneurysm, 277–278

Biliary tree stone disease, changes inmanagement of, 252–253

Burn injury, effect on cardiac function,179–180

hypermetabolic response to, 178–179

propranolol administration for 1 yearafter, 187–191

adverse events in, 189–191

propranolol in, body composition and,194–195

cardiac and blood pressuremeasurements to assess, 194

hormone assessments in, 195

indirect colorimetry to assess, 194

methods of administration ofand safety guidelines for,192–193

Burn patients, adult, severely burned, betablockade in, 180

pediatric, propranolol in, 177–197

severely burned, propranolol inacute hospitalization of,181–187

propranolol to reducehypermetabolicresponse in, 180–181

C

California State Inpatient Database, ofduodenal switch patients, long-termoutcomes of, readmissions analysis of,165–167, 168

Cardiac function, effect of burn injury on,179–180

Chemistry tests, preoperative, 88

Chest radiography, preoperative, 85

Children, burn patients, propranolol in,177–197

diagnosis of appendicitis in, 322

severely burned, propranolol in acutehospitalization of, 181–187

propranolol to reducehypermetabolic response in,180–181

Cholecystectomy, 227, 231–234

laparoscopic, 30–31

versus open surgery, in gallbladder cancer, 244–245

Coagulation studies, preoperative, 88

Colectomy, laparoscopic, benefits of, 32–33

controversies in, 39

factors affecting use of, 35–38

future of, 39–40

outcomes of, compared to opensurgery, 31–32

roadblocks to adoption of, 38–39

trends in use of, nationwide,33–35

Colon cancer, incidence of, 199–200

isolated tumor cells in, 207–208

sentinel lymph node biopsy mapping,205–207

staging of, general considerations for,200–202

historical, 200

improved, lymph node yield for,202–203

improving diagnostic accuracy of,208

lymph node ratio and, 203

optimal means of, 199–211

ultrastaging of, 203–205

Colon resection, laparoscopic, 29–43

D

Diabetes, criteria for diagnosis of, 293

incidence of, 293

Do-not-resuscitate orders, preexisting,elderly emergency general surgerypatients with, characteristics of,214–215

331INDEX

elderly patients with, emergencyoperation in, outcomesassociated with, 217–221

reasons to consent toemergency operation,216–217

emergency surgery in, excessmortality associated with,221–223

preoperative, incidence of, 213–214

Do-not-resuscitate status, effect onpostoperative mortality in elderly,following emergency surgery, 213–225

Duodenal switch, 153–176

and Roux-en-Y gastric bypass, patientcharacteristics for, 161–162

thirty-day outcomes for, 162–163,164

complications of, 171–172

history of, 154

laparoscopic, and laparoscopic Roux-en-Y gastric bypass, patientcharacteristics for, 162, 163

thirty-day outcomes for,164–165, 166

morbidity for, long-term, 168–171

short-term, 168

mortality associated with, 172–174

National Safety Quality ImprovementProgram database for, 159–161

risks associated with, 154

safety of, determination of, 155

University of Southern Californiadataset for, 155–159

E

Elderly patients, do-not-resuscitate status,effect on postoperative mortality,following emergency surgery, 213–225

Electrocardiography, preoperative, 84–85

Emergency surgery, and effect of do-not-resuscitate status, on postoperativemortality in elderly, 213–225

G

Gall bladder cancer, incidental, 227–249

adjuvant therapy in, 240–241

definitions of, 228

diagnosis of, 228–230, 231, 232,233

incidence of, 231

management of, 231–235

reoperation in, indications/contraindications for, 240

resection of, follow-up after, 245

surgery for, 237–239, 240

results of, 242–244

timing of, 235

workup before reoperation,235–236

laparoscopic cholecystectomy versusopen surgery in, 244–245

laparoscopy in, staging of, 237

prevention of gall bladder perforationduring treatment of, 245–246

Gall stone disease, 227

Gastrinoma(s), diagnosis of, 63–65

incidence of, 60

localzation of, invasive, 70–71

noninvasive studies for, 65–70

lymph node involvement and survivalin, 62–63

metastatic potential and survival in, 62

size and location of, 60–62

treatment of, advanced, 73–74

medical, 71

MEN1 and ZES in, 71–72

sporadic, treatment of, 72–73

surgical, 71–74

H

Hemoglobin A1c studies, 88

Hemoglobin/hematocrit, preoperative testingof, 85

Hernia(s), giant ventral, cause of, 6–7

classification of, 9

definition of, 6

description of, 1–2

repair of, 1–27

complications of, 22–24

component separationtechnique in, 17–19

endoscopic componentseparation in, 19–20

flaps and grafts in, 21–22

intra-abdominal visceraresection in, 22

332 INDEX

Hernia(s) (continued)

medialization in, 20

operative approaches for,14–17

progressivepneumoperitoneumpreceding, 20–21

tissue expansion for, 22

surgical anatomy of, 2–5

incisional, cardiovascular assessment in,10

classification of, 7, 8

clinical presentation of, 8, 9

host factors associated with, 7

preoperative workup in, 10

repair of, prosthetic material for,11–14

repair of, preoperative testing for, 90–91,92, 93

Hyperglycemia, causes of, 292–294

stress-induced, 287–297

future directions in, 295

hormones and cytokinesmediating, 288

morbidity and mortality associatedwith, 289–290

risk factors for, 288

treatment of, in critically illpatients, 290–291

in trauma patients, 291–292

Hypermetabolic response, to burn injury,178–179

I

Irrigation, basic science of, 112–113

cleansing abdomen with, clinical dataon, 112–113

current clinical data on, 114–116

L

Laboratory tests, preoperative, currentguidelines for, refinement/definition of,91–95

current recommendations for,83–84

current use in North America,89–91

goals, benefits, and risks of, 82–83

in older patients, 84

specific current, data for use of,84–88

required for ambulatory surgery, 81–98

Laparoscopic colon resection. See Colectomy,laparoscopic.

Laparoscopic surgery, impact of, 254–255

participation of surgical residents in,safety of, 49–52

Laparoscopic surgery training, for surgicalresidents, 268

Laparoscopy, complex versus simple, 30–31

in diagnosis of appendicitis, 320

Lymph node yield, for improved staging ofcolon cancer, 203

O

Obesity, morbid, duodenal switch for. SeeDuodenal switch.

P

Pancreaticoduodenectomy, improvingoutcomes of, 107–108

indications for, 104

readmission after, Central PancreasConsortium and, 103–106

does fast tracking increase?,106–107

factors affecting, 99–110

literature search on, 101

summary of literature on, 101

Peptic ulcer disease, benign, changes inmanagement of, 252

Peritoneal lavage, history of, 111–112

with suction, during laraposcopicappendectomy for perforatedappendicitis, 111–118

Pneumoperitoneum, progressive, for repair ofgiant ventral hernia, 20–21

Pregnancy, appendicitis during, 128–130

diagnosis of appendicitis in, 320–322

Pregnancy tests, 88

Propranolol, administration for 1 year afterburn injury, 187–191

effect on body composition, 189, 190

in burn injury, body composition and,194–195

cardiac and blood pressuremeasurements to assess, 194

hormone assessments in, 195

333INDEX

indirect colorimetry to assess, 194

in pediatric burn patients, 177–197

methods of administration of and safetyguidelines for, in burn injury,192–193

R

Roux-en-Y gastric bypass, and duodenalswitch, patient characteristics for,161–162

thrity-day outcomes for, 162–163,164

laparoscopic, and laparoscopic duodenalswitch, patient characteristics for,162, 163

thrity-day outcomes for,164–165, 166

S

Statin therapy, in abdominal aortic aneurysm,276–277

Surgical Care and Outcomes AssessmentProgram, 307–308

Surgical residency programs, variable qualityof, 258–259

Surgical resident(s), adding skills to residencytraining for, 269–270

American Board of Surgeryexamination performance and,260–261

defining and updating of curriculum for,263–264

earlier specialty focus for, 267–268

environmental and technological changein disease management and,252–254

general surgery, training issues and,251–269

graded responsibility, autonomy, andindependent functioning of,261–263

impact of 80-hour workweek on,256–258

improving of efficiency of learning for,264–265

in continuation of care and hand-offs,53–54

increased length of residency for,268–269

laparoscopic surgery training for, 268

opinions on continuing training,259–260

participation in laparoscopic surgery,safety of, 49–52

participation in surgical procedures,safety of, 46–49

performance of, impact of stress on,54–55

simulation and structured teaching for,265–266

training of, safety of, 45–57

work restriction and safety of, 52–53

T

Tissue expansion, for repair of giant ventralhernia, 22

Traumatic injuries, changes in managementof, 253–254

V

Vascular surgery, abdominal, changes in, 253

Z

Zollinger-Ellison syndrome, currentmanagement of, 59–79

gastrinoma as cause of. See Gastrinoma(s).